Preliminary reports suggest conolidine may possibly inhibit specific ion channels, cutting down neuronal excitability and restricting discomfort signals. This mechanism is particularly pertinent in neuropathic suffering, where by irregular signaling causes persistent discomfort. Furthermore, conolidine seems to impact G protein-coupled receptor (GP